Edward D Zdobylak, MD | |
1901 W 3rd, Suitea, Elk City, OK 73644-7364 | |
(580) 225-2513 | |
(580) 303-5863 |
Full Name | Edward D Zdobylak |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Neurology |
Location | 1901 W 3rd, Elk City, Oklahoma |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558384545 | NPI | - | NPPES |
000000939921 | Other | IN | ANTHEM LEGACY # |
200377800 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 01051068A (Indiana) | Primary |
Entity Name | Rush Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497726020 PECOS PAC ID: 7012802754 Enrollment ID: O20040220000164 |
News Archive
Animal-assisted therapy can foster social competence in patients with brain injuries and increase their emotional involvement during therapy. These were the findings of a clinical trial conducted by psychologists from the University of Basel and published in the journal Scientific Reports.
The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.
A team of researchers from Queen's University Belfast, led by Professor Ryan Donnelly, Professor of Pharmaceutical Technology are developing a new type of skin patch (microarray patch) that administers drugs directly into the bloodstream through thousands of individual "microneedles" which are being tested as a possible answer to the antibiotic resistance crisis.
A European group of scientists are working on the development of a breakthrough, compact, cost-effective retinal scanner that will play a key role in targeting the early diagnosis of retinal diseases that are worldwide leading causes of blindness.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Edward D Zdobylak, MD Po Box 2339, Elk City, OK 73648-2339 Ph: (805) 225-2513 | Edward D Zdobylak, MD 1901 W 3rd, Suitea, Elk City, OK 73644-7364 Ph: (580) 225-2513 |
News Archive
Animal-assisted therapy can foster social competence in patients with brain injuries and increase their emotional involvement during therapy. These were the findings of a clinical trial conducted by psychologists from the University of Basel and published in the journal Scientific Reports.
The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.
A team of researchers from Queen's University Belfast, led by Professor Ryan Donnelly, Professor of Pharmaceutical Technology are developing a new type of skin patch (microarray patch) that administers drugs directly into the bloodstream through thousands of individual "microneedles" which are being tested as a possible answer to the antibiotic resistance crisis.
A European group of scientists are working on the development of a breakthrough, compact, cost-effective retinal scanner that will play a key role in targeting the early diagnosis of retinal diseases that are worldwide leading causes of blindness.
› Verified 6 days ago